Global Recombinant Protein Drugs Market Research Report 2018

Publisher Name :
Date: 02-May-2018
No. of pages: 113
Inquire Before Buying

This report studies the global Recombinant Protein Drugs market status and forecast, categorizes the global Recombinant Protein Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China and other regions (India, Southeast Asia, Central & South America, and Middle East & Africa).

The global Recombinant Protein Drugs market is valued at xx million US$ in 2017 and is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx.x % between 2018 and 2025.

The major manufacturers covered in this report

- Novo Nordisk

- Amgen

- Sanofi

- Eli Lilly

- Merck Serono

- Ortho Biotech

- Roche

- Kyowa Hakko Kirin

- Pharmingen

- Abcam

- GenSci

- SL PHARM

- Dongbao Pharm

- Ankebio

- NCPC

- Heng Rui

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

- North America

- Europe

- China

- Japan

- Other Regions (India, Southeast Asia, Central & South America and Middle East & Africa)

The regional scope of the study is as follows:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Rest of Asia-Pacific

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- - Rest of Europe

- Central & South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Saudi Arabia

- - Turkey

- - Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Recombinant DNA

- Recombinant RNA

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

- Pharmaceutical Industry

- Other

The study objectives of this report are:

- To analyze and study the global Recombinant Protein Drugs capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);

- Focuses on the key Recombinant Protein Drugs manufacturers, to study the capacity, production, value, market share and development plans in future.

- Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.

- To define, describe and forecast the market by type, application and region.

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends and factors driving or inhibiting the market growth.

- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.

- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Recombinant Protein Drugs are as follows:

- History Year: 2013-2017

- Base Year: 2017

- Estimated Year: 2018

- Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Recombinant Protein Drugs Manufacturers

Recombinant Protein Drugs Distributors/Traders/Wholesalers

Recombinant Protein Drugs Subcomponent Manufacturers

Industry Association

Downstream Vendors

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Regional and country-level analysis of the Recombinant Protein Drugs market, by end-use.

Detailed analysis and profiles of additional market players.

Global Recombinant Protein Drugs Market Research Report 2018

Table of Contents
Global Recombinant Protein Drugs Market Research Report 2018
1 Recombinant Protein Drugs Market Overview
1.1 Product Overview and Scope of Recombinant Protein Drugs
1.2 Recombinant Protein Drugs Segment by Type (Product Category)
1.2.1 Global Recombinant Protein Drugs Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Recombinant Protein Drugs Production Market Share by Type (Product Category) in 2017
1.2.3 Recombinant DNA
1.2.4 Recombinant RNA
1.3 Global Recombinant Protein Drugs Segment by Application
1.3.1 Recombinant Protein Drugs Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Pharmaceutical Industry
1.3.3 Other
1.4 Global Recombinant Protein Drugs Market by Region (2013-2025)
1.4.1 Global Recombinant Protein Drugs Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Recombinant Protein Drugs (2013-2025)
1.5.1 Global Recombinant Protein Drugs Revenue Status and Outlook (2013-2025)
1.5.2 Global Recombinant Protein Drugs Capacity, Production Status and Outlook (2013-2025)
2 Global Recombinant Protein Drugs Market Competition by Manufacturers
2.1 Global Recombinant Protein Drugs Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Recombinant Protein Drugs Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Recombinant Protein Drugs Production and Share by Manufacturers (2013-2018)
2.2 Global Recombinant Protein Drugs Revenue and Share by Manufacturers (2013-2018)
2.3 Global Recombinant Protein Drugs Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Recombinant Protein Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Recombinant Protein Drugs Market Competitive Situation and Trends
2.5.1 Recombinant Protein Drugs Market Concentration Rate
2.5.2 Recombinant Protein Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Recombinant Protein Drugs Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Recombinant Protein Drugs Capacity and Market Share by Region (2013-2018)
3.2 Global Recombinant Protein Drugs Production and Market Share by Region (2013-2018)
3.3 Global Recombinant Protein Drugs Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Recombinant Protein Drugs Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Recombinant Protein Drugs Consumption by Region (2013-2018)
4.2 North America Recombinant Protein Drugs Production, Consumption, Export, Import (2013-2018)
4.3 Europe Recombinant Protein Drugs Production, Consumption, Export, Import (2013-2018)
4.4 China Recombinant Protein Drugs Production, Consumption, Export, Import (2013-2018)
4.5 Japan Recombinant Protein Drugs Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Recombinant Protein Drugs Production, Consumption, Export, Import (2013-2018)
4.7 India Recombinant Protein Drugs Production, Consumption, Export, Import (2013-2018)
4.8 South America Recombinant Protein Drugs Production, Consumption, Export, Import (2013-2018)
4.9 Middle East and Africa Recombinant Protein Drugs Production, Consumption, Export, Import (2013-2018)
5 Global Recombinant Protein Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Recombinant Protein Drugs Production and Market Share by Type (2013-2018)
5.2 Global Recombinant Protein Drugs Revenue and Market Share by Type (2013-2018)
5.3 Global Recombinant Protein Drugs Price by Type (2013-2018)
5.4 Global Recombinant Protein Drugs Production Growth by Type (2013-2018)
6 Global Recombinant Protein Drugs Market Analysis by Application
6.1 Global Recombinant Protein Drugs Consumption and Market Share by Application (2013-2018)
6.2 Global Recombinant Protein Drugs Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Recombinant Protein Drugs Manufacturers Profiles/Analysis
7.1 Novo Nordisk
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Recombinant Protein Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Novo Nordisk Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Amgen
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Recombinant Protein Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Amgen Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Sanofi
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Recombinant Protein Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Sanofi Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Eli Lilly
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Recombinant Protein Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Eli Lilly Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Merck Serono
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Recombinant Protein Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Merck Serono Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.5.4 Main Business/Business Overview
7.6 Ortho Biotech
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Recombinant Protein Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Ortho Biotech Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Roche
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Recombinant Protein Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Roche Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Kyowa Hakko Kirin
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Recombinant Protein Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Kyowa Hakko Kirin Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Pharmingen
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Recombinant Protein Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Pharmingen Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.10 Abcam
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Recombinant Protein Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Abcam Recombinant Protein Drugs Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 GenSci
7.12 SL PHARM
7.13 Dongbao Pharm
7.14 Ankebio
7.15 NCPC
7.16 Heng Rui
8 Recombinant Protein Drugs Manufacturing Cost Analysis
8.1 Recombinant Protein Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Recombinant Protein Drugs
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Recombinant Protein Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Recombinant Protein Drugs Market Forecast (2018-2025)
12.1 Global Recombinant Protein Drugs Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Recombinant Protein Drugs Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Recombinant Protein Drugs Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Recombinant Protein Drugs Price and Trend Forecast (2018-2025)
12.2 Global Recombinant Protein Drugs Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Recombinant Protein Drugs Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Recombinant Protein Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.3.1 North America Recombinant Protein Drugs Consumption Forecast (2018-2025)
12.3.2 Europe Recombinant Protein Drugs Consumption Forecast (2018-2025)
12.3.3 China Recombinant Protein Drugs Consumption Forecast (2018-2025)
12.3.4 Japan Recombinant Protein Drugs Consumption Forecast (2018-2025)
12.3.5 Southeast Asia Recombinant Protein Drugs Consumption Forecast (2018-2025)
12.3.6 India Recombinant Protein Drugs Consumption Forecast (2018-2025)
12.3.7 South America Recombinant Protein Drugs Consumption Forecast (2018-2025)
12.3.8 Middle East Recombinant Protein Drugs Consumption Forecast (2018-2025)
12.4 Global Recombinant Protein Drugs Production, Revenue and Price Forecast by Type (2018-2025)
12.5 Global Recombinant Protein Drugs Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Recombinant Protein Drugs
Figure Global Recombinant Protein Drugs Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Recombinant Protein Drugs Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Recombinant DNA
Table Major Manufacturers of Recombinant DNA
Figure Product Picture of Recombinant RNA
Table Major Manufacturers of Recombinant RNA
Figure Global Recombinant Protein Drugs Consumption (K Doses) by Applications (2013-2025)
Figure Global Recombinant Protein Drugs Consumption Market Share by Applications in 2017
Figure Pharmaceutical Industry Examples
Table Key Downstream Customer in Pharmaceutical Industry
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Recombinant Protein Drugs Market Size (Million USD), Comparison (K Doses) and CAGR (%) by Regions (2013-2025)
Figure North America Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Recombinant Protein Drugs Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Recombinant Protein Drugs Capacity, Production (K Doses) Status and Outlook (2013-2025)
Figure Global Recombinant Protein Drugs Major Players Product Capacity (K Doses) (2013-2018)
Table Global Recombinant Protein Drugs Capacity (K Doses) of Key Manufacturers (2013-2018)
Table Global Recombinant Protein Drugs Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Recombinant Protein Drugs Capacity (K Doses) of Key Manufacturers in 2017
Figure Global Recombinant Protein Drugs Capacity (K Doses) of Key Manufacturers in 2018
Figure Global Recombinant Protein Drugs Major Players Product Production (K Doses) (2013-2018)
Table Global Recombinant Protein Drugs Production (K Doses) of Key Manufacturers (2013-2018)
Table Global Recombinant Protein Drugs Production Share by Manufacturers (2013-2018)
Figure 2017 Recombinant Protein Drugs Production Share by Manufacturers
Figure 2017 Recombinant Protein Drugs Production Share by Manufacturers
Figure Global Recombinant Protein Drugs Major Players Product Revenue (Million USD) (2013-2018)
Table Global Recombinant Protein Drugs Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Recombinant Protein Drugs Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Recombinant Protein Drugs Revenue Share by Manufacturers
Table 2018 Global Recombinant Protein Drugs Revenue Share by Manufacturers
Table Global Market Recombinant Protein Drugs Average Price (USD/Dose) of Key Manufacturers (2013-2018)
Figure Global Market Recombinant Protein Drugs Average Price (USD/Dose) of Key Manufacturers in 2017
Table Manufacturers Recombinant Protein Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Recombinant Protein Drugs Product Category
Figure Recombinant Protein Drugs Market Share of Top 3 Manufacturers
Figure Recombinant Protein Drugs Market Share of Top 5 Manufacturers
Table Global Recombinant Protein Drugs Capacity (K Doses) by Region (2013-2018)
Figure Global Recombinant Protein Drugs Capacity Market Share by Region (2013-2018)
Figure Global Recombinant Protein Drugs Capacity Market Share by Region (2013-2018)
Figure 2017 Global Recombinant Protein Drugs Capacity Market Share by Region
Table Global Recombinant Protein Drugs Production by Region (2013-2018)
Figure Global Recombinant Protein Drugs Production (K Doses) by Region (2013-2018)
Figure Global Recombinant Protein Drugs Production Market Share by Region (2013-2018)
Figure 2017 Global Recombinant Protein Drugs Production Market Share by Region
Table Global Recombinant Protein Drugs Revenue (Million USD) by Region (2013-2018)
Table Global Recombinant Protein Drugs Revenue Market Share by Region (2013-2018)
Figure Global Recombinant Protein Drugs Revenue Market Share by Region (2013-2018)
Table 2017 Global Recombinant Protein Drugs Revenue Market Share by Region
Figure Global Recombinant Protein Drugs Capacity, Production (K Doses) and Growth Rate (2013-2018)
Table Global Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table North America Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Europe Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table China Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Japan Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Global Recombinant Protein Drugs Consumption (K Doses) Market by Region (2013-2018)
Table Global Recombinant Protein Drugs Consumption Market Share by Region (2013-2018)
Figure Global Recombinant Protein Drugs Consumption Market Share by Region (2013-2018)
Figure 2017 Global Recombinant Protein Drugs Consumption (K Doses) Market Share by Region
Table North America Recombinant Protein Drugs Production, Consumption, Import & Export (K Doses) (2013-2018)
Table Europe Recombinant Protein Drugs Production, Consumption, Import & Export (K Doses) (2013-2018)
Table China Recombinant Protein Drugs Production, Consumption, Import & Export (K Doses) (2013-2018)
Table Japan Recombinant Protein Drugs Production, Consumption, Import & Export (K Doses) (2013-2018)
Table Global Recombinant Protein Drugs Production (K Doses) by Type (2013-2018)
Table Global Recombinant Protein Drugs Production Share by Type (2013-2018)
Figure Production Market Share of Recombinant Protein Drugs by Type (2013-2018)
Figure 2017 Production Market Share of Recombinant Protein Drugs by Type
Table Global Recombinant Protein Drugs Revenue (Million USD) by Type (2013-2018)
Table Global Recombinant Protein Drugs Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Recombinant Protein Drugs by Type (2013-2018)
Figure 2017 Revenue Market Share of Recombinant Protein Drugs by Type
Table Global Recombinant Protein Drugs Price (USD/Dose) by Type (2013-2018)
Figure Global Recombinant Protein Drugs Production Growth by Type (2013-2018)
Table Global Recombinant Protein Drugs Consumption (K Doses) by Application (2013-2018)
Table Global Recombinant Protein Drugs Consumption Market Share by Application (2013-2018)
Figure Global Recombinant Protein Drugs Consumption Market Share by Applications (2013-2018)
Figure Global Recombinant Protein Drugs Consumption Market Share by Application in 2017
Table Global Recombinant Protein Drugs Consumption Growth Rate by Application (2013-2018)
Figure Global Recombinant Protein Drugs Consumption Growth Rate by Application (2013-2018)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Novo Nordisk Recombinant Protein Drugs Production Growth Rate (2013-2018)
Figure Novo Nordisk Recombinant Protein Drugs Production Market Share (2013-2018)
Figure Novo Nordisk Recombinant Protein Drugs Revenue Market Share (2013-2018)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Amgen Recombinant Protein Drugs Production Growth Rate (2013-2018)
Figure Amgen Recombinant Protein Drugs Production Market Share (2013-2018)
Figure Amgen Recombinant Protein Drugs Revenue Market Share (2013-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi Recombinant Protein Drugs Production Growth Rate (2013-2018)
Figure Sanofi Recombinant Protein Drugs Production Market Share (2013-2018)
Figure Sanofi Recombinant Protein Drugs Revenue Market Share (2013-2018)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Eli Lilly Recombinant Protein Drugs Production Growth Rate (2013-2018)
Figure Eli Lilly Recombinant Protein Drugs Production Market Share (2013-2018)
Figure Eli Lilly Recombinant Protein Drugs Revenue Market Share (2013-2018)
Table Merck Serono Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Serono Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merck Serono Recombinant Protein Drugs Production Growth Rate (2013-2018)
Figure Merck Serono Recombinant Protein Drugs Production Market Share (2013-2018)
Figure Merck Serono Recombinant Protein Drugs Revenue Market Share (2013-2018)
Table Ortho Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Ortho Biotech Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Ortho Biotech Recombinant Protein Drugs Production Growth Rate (2013-2018)
Figure Ortho Biotech Recombinant Protein Drugs Production Market Share (2013-2018)
Figure Ortho Biotech Recombinant Protein Drugs Revenue Market Share (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Roche Recombinant Protein Drugs Production Growth Rate (2013-2018)
Figure Roche Recombinant Protein Drugs Production Market Share (2013-2018)
Figure Roche Recombinant Protein Drugs Revenue Market Share (2013-2018)
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kyowa Hakko Kirin Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Production Growth Rate (2013-2018)
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Production Market Share (2013-2018)
Figure Kyowa Hakko Kirin Recombinant Protein Drugs Revenue Market Share (2013-2018)
Table Pharmingen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pharmingen Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Pharmingen Recombinant Protein Drugs Production Growth Rate (2013-2018)
Figure Pharmingen Recombinant Protein Drugs Production Market Share (2013-2018)
Figure Pharmingen Recombinant Protein Drugs Revenue Market Share (2013-2018)
Table Abcam Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abcam Recombinant Protein Drugs Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Abcam Recombinant Protein Drugs Production Growth Rate (2013-2018)
Figure Abcam Recombinant Protein Drugs Production Market Share (2013-2018)
Figure Abcam Recombinant Protein Drugs Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Protein Drugs
Figure Manufacturing Process Analysis of Recombinant Protein Drugs
Figure Recombinant Protein Drugs Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Protein Drugs Major Manufacturers in 2017
Table Major Buyers of Recombinant Protein Drugs
Table Distributors/Traders List
Figure Global Recombinant Protein Drugs Capacity, Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure Global Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Recombinant Protein Drugs Price (Million USD) and Trend Forecast (2018-2025)
Table Global Recombinant Protein Drugs Production (K Doses) Forecast by Region (2018-2025)
Figure Global Recombinant Protein Drugs Production Market Share Forecast by Region (2018-2025)
Table Global Recombinant Protein Drugs Consumption (K Doses) Forecast by Region (2018-2025)
Figure Global Recombinant Protein Drugs Consumption Market Share Forecast by Region (2018-2025)
Figure North America Recombinant Protein Drugs Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure North America Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Recombinant Protein Drugs Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure Europe Recombinant Protein Drugs Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure Europe Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Recombinant Protein Drugs Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure China Recombinant Protein Drugs Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure China Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Recombinant Protein Drugs Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure Japan Recombinant Protein Drugs Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure Japan Recombinant Protein Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Recombinant Protein Drugs Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Table Global Recombinant Protein Drugs Production (K Doses) Forecast by Type (2018-2025)
Figure Global Recombinant Protein Drugs Production (K Doses) Forecast by Type (2018-2025)
Table Global Recombinant Protein Drugs Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Recombinant Protein Drugs Revenue Market Share Forecast by Type (2018-2025)
Table Global Recombinant Protein Drugs Price Forecast by Type (2018-2025)
Table Global Recombinant Protein Drugs Consumption (K Doses) Forecast by Application (2018-2025)
Figure Global Recombinant Protein Drugs Consumption (K Doses) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
  • Global Shark Liver Oils Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 102
    Shark liver oil is an oil obtained from the livers of sharks. Scope of the Report: Shark liver oi is promoted as a dietary supplement, and additional claims have been made that it can treat other maladies such as cancer, HIV, radiation illness, swine flu and the common cold. The worldwide market for Shark Liver Oils is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new......
  • Global Neurodegenerative Disease Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 120
    Neurodegenerative disease or neurodegeneration refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventually memory loss. Scope of the Report: This report focuses on the Neurodegenerative Disease in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and......
  • Global Microsclerotherapy Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 123
    The very thin and tiny veins that look like a spider web below the skin is known as spider veins or thread veins. Spider vein are also known as small varicose veins. They are caused because of the malfunctioning of the valves in the veins. The bloods gets backed up in the veins resulting into swelling. Microsclerotherapy is one of the best technique to treat spider veins. It involves injecting a substance called as sclerosant, which destroys the veins over a period of time and makes it disappear......
  • Global Micro-ultrasound Systems Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 108
    Micro-ultrasound is capable of anatomical imaging. Micro-ultrasound systems generate the sound waves from transducers and penetrate the living tissue for getting the image in 2D or 3D. Micro-ultrasound are very useful for studies smaller animal for research purpose as the range of micro-ultrasound is from 15-20 MHz Micro-ultrasound also helps in early detection of tumor in the body ranging from 50 µm or above. Micro-ultrasound has many application which enable the micro-injection of drug, detect......
  • Global Minimally Invasive Neurosurgery Devices Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 124
    Minimally Invasive Neurosurgery is performed to treat disease occurring in various parts of brain, spinal cord or skull base through a small opening. Diseased area may require repair, removal and in the worst cases replacement which is being done through neurosurgery. Neurosurgical device used for the visualization purpose inside the human brain or spinal cord is known as "Endoscope" which is kind of a small microscope inserted through minimal invasion. Scope of the Report:......
  • Global Mobile Endoscopic Workstations Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 116
    The mobile endoscopic workstations is surgical devices which are used for effective endoscopic surgeries. The mobile endoscopic workstations can accommodate all the required endoscopic devices that are used in an endoscopic surgery. Medical endoscopic workstations comprises a number of features which can be upgraded for user safety and comfort. Scope of the Report: This report focuses on the Mobile Endoscopic Workstations in global market, especially in North America, Europ......
  • Global Monoclonal Antibody Therapeutics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 120
    For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body. Scope of the Report: This report focuses on the Monoclonal Antibody Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle Eas......
  • Global Monoclonal Antibody Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 116
    For transferring the insulin a device is used that is known as insulin patch pump. Owing to the presence of the adhesive, the insulin patch pump gets directly attached to the body. The presence of the adhesive avoids the requirement of the infusion set and tubing for attaching the pump to the body. Scope of the Report: This report focuses on the Monoclonal Antibody Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East a......
  • Global Mycology Immunoassays Testing Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 16-Nov-2018        Price: US 3480 Onwards        Pages: 124
    he frequency of invasive fungal infections has dramatically increased in the recent years and has high mortality and morbidity. Accurate and early diagnosis is very important for the appropriate antifungal therapy. Conventional techniques like microbiology, radiological and histological remain the basis of diagnosis but have limited impact on clinical decision making. There is always a need to characterize fungi accurately and quickly, which can be done by mycology immunoassays test. The fungi a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs